Covered recipient · General Payments record
MAHANA S FISHER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,780.65
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $394.62 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $168.97 | 13 |
| Indivior Inc. | $43.77 | 2 |
| PFIZER INC. | $42.61 | 2 |
| Braeburn Inc. | $35.34 | 2 |
| Otsuka America Pharmaceutical, Inc. | $34.59 | 2 |
| Axsome Therapeutics, Inc. | $19.44 | 1 |
| ITI, Inc. | $18.63 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.62 | 1 |
| Vanda Pharmaceuticals Inc. | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.75 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732635 | CMS |
| ABBVIE INC. | $10.51 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732637 | CMS |
| ABBVIE INC. | $9.77 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732639 | CMS |
| ABBVIE INC. | $10.72 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732641 | CMS |
| ABBVIE INC. | $25.63 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732643 | CMS |
| ABBVIE INC. | $12.49 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732645 | CMS |
| ABBVIE INC. | $8.07 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732647 | CMS |
| ABBVIE INC. | $19.49 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732649 | CMS |
| ABBVIE INC. | $1.77 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732651 | CMS |
| ABBVIE INC. | $19.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732653 | CMS |
| ABBVIE INC. | $23.88 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732655 | CMS |
| ABBVIE INC. | $3.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732657 | CMS |
| ABBVIE INC. | $2.64 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103732659 | CMS |
| Axsome Therapeutics, Inc. | $19.44 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148300216 | CMS |
| Braeburn Inc. | $16.82 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125604642 | CMS |
| Braeburn Inc. | $18.52 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125604644 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.62 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101495538 | CMS |
| Indivior Inc. | $25.00 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144527778 | CMS |
| Indivior Inc. | $18.77 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144527780 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.63 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143225248 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.05 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118892842 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.54 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118892844 | CMS |
| PFIZER INC. | $15.98 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223057 | CMS |
| PFIZER INC. | $26.63 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131620913 | CMS |
| Vanda Pharmaceuticals Inc. | $14.65 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133902453 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.